Screener
GoodRx Holdings, Inc. GDRX Total Cost of Revenue
Total Cost of Revenue at other companies
Other financials
Where this comes from
Reported directly by GoodRx Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization.
The source filing: GoodRx Holdings, Inc.’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 4:09 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001809519-26-000152
FAQ
- What is GoodRx Holdings, Inc.'s total cost of revenue?
- GoodRx Holdings, Inc. (GDRX) reported total cost of revenue of $21M in Q2 2026.
- How has GoodRx Holdings, Inc.'s total cost of revenue changed year-over-year?
- GoodRx Holdings, Inc.'s total cost of revenue increased by 57.3% year-over-year, from $13.35M to $21M.
- What is the long-term trend for GoodRx Holdings, Inc.'s total cost of revenue?
- Over 4 years (2021 to 2025), GoodRx Holdings, Inc.'s total cost of revenue has grown at a 5.4% compound annual growth rate (CAGR), from $46.72M to $57.6M.
- What does total cost of revenue mean?
- The aggregate of all direct costs attributable to producing goods and delivering services that generated the company's revenue, including materials, labor, and overhead.
Ask your AI about GoodRx Holdings, Inc.'s total cost of revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude